Screener
Prime Medicine PRME Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$42.11M+19.9% | -$49.12M+5.3% | -$46.08M-9.0% | -$50.58M+3.7% | -$52.59M+4.9% | ||
| $1.79M-4.2% | $1.86M+9.2% | $1.88M+9.3% | $1.88M+20.7% | $1.86M+21.2% | ||
| $4.87M-23.1% | $4.64M-18.3% | $4.52M-24.0% | $12.75M+86.7% | $6.33M-21.8% | ||
| -$41.05M+0.9% | -$42.71M+12.6% | -$37.26M— | -$35.04M-35.2% | -$41.41M+9.0% | ||
| $46K-97.1% | $214K-91.2% | $290K-83.8% | $247K-80.7% | $1.57M-17.4% | ||
| $24.03M— | $43.39M+191% | —— | -$92.12M-283% | —— | ||
| $361K+83.2% | $393K-93.5% | $562K+56,100% | $144.75M+276% | $197K+463% | ||
| -$16.66M+56.7% | $1.07M+101% | -$8.36M-113% | —— | -$38.44M— | ||
| -$41.09M+4.4% | -$42.92M+16.3% | -$37.55M— | -$35.29M-29.8% | -$42.98M+9.3% |
FAQ
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.1M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $797.0K of capital expenditures, Prime Medicine's free cash flow was -$156.8M over the trailing twelve months, up 7.1% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.